Biowatch Holding ApS: Financial statements 2025
CVR: 36562404
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Biowatch Holding ApS (CVR 36562404) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -33,769 and a net result of DKK -3,649,958 compared with DKK -5,209,852 the year before. Equity in the 2025 report amounted to DKK 507,614. The solvency ratio was 94.5%.
- Gross Profit
- DKK -33,769
- Profit/Loss
- DKK -3,649,958
- Equity
- DKK 507,614
- Total Assets
- DKK 537,089
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -34 t. | -3.6 mio. | 508 t. | 0 |
| 2024 | - | -111 t. | -5.2 mio. | 3.7 mio. | 0 |
| 2023 | - | -134 t. | -2.1 mio. | 8.9 mio. | 1 |
| 2022 | - | -127 t. | -3.5 mio. | 5 mio. | - |
| 2021 | - | -7 t. | -1.2 mio. | 3.4 mio. | - |
Official annual report
How creditworthy is Biowatch Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of September 12, 2025, Svend Tøttrup has joined the board of directors of Biowatch Holding ApS.
As of September 11, 2025, Svend Tøttrup has left the board of directors of Biowatch Holding ApS.
Biowatch Holding ApS has published its annual report for 2024. Gross profit came to DKK -110,852, and the net result was DKK -5,209,852.
As of January 10, 2025, New Normal Labs ApS is registered as an owner of Biowatch Holding ApS with an ownership share of 10%.
As of January 10, 2025, AN2020 ApS is registered as an owner of Biowatch Holding ApS with an ownership share of 10%.
As of January 10, 2025, is registered as an owner of Biowatch Holding ApS with an ownership share of 10%.
About Biowatch Holding ApS
Biowatch Holding ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2015. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company was previously named Biowatch Holding IVS and BioWatch IVS. The management consists of Mikkel Thykjær Jørgensen. The board consists of Svend Tøttrup (chair), Claus-Henrik Rasmussen, Martin Franke Amor and Mikkel Thykjær Jørgensen. The company's owners include JKP HOLDING ApS, WESTEROS ApS and New Normal Labs ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -33,769 and a net result of DKK -3,649,958 compared with DKK -5,209,852 the year before. Equity in the 2025 report amounted to DKK 507,614.